Several efforts have been made to find out the association of type 2 diabetes mellitus (T2DM) with increased risk of cognitive impairment, but still, the concept behind the T2DM-induced cognitive impairment is largely unknown. The present study is conducted to determine the relationship between the adverse level of glycated hemoglobin (hba1c) and impact on cognitive functions in patients with type 2 diabetes.
Consenting adults (n=74) with type 2 diabetes, no prior cognitive impairment disorder, was prospectively observed using Cognitive Testing Interview Guide with their hba1c level. The primary outcome measure was to evolve the correlation between hba1c level, age and cognition demographics including vision, hearing, cognitive functioning, walking, self- care, communication, and general health.
For the the18months time period between March 2017-August 2018, 596 people were enrolled in the study, 323 present detailed histories of disease and 119 were able to produce the current hba1c report. Finally, (n=74) completed cognitive tests. The incidence of complications in cognitive functions was significantly associated with the hba1c level. Each cognitive demographics vision, hearing, cognitive functioning, walking, self-care, communication, and general health were related to hba1c in type 2 diabetes patients (95% confidence interval P<0.0001).
Poor cognitive functions increase the risk of severe health issues which affects the day to day life of people with type 2 diabetes. As our study demonstrates highly significant (P<0.0001) results in every cognitive demographics which states the association of cognitive functions with T2DM.